214 related articles for article (PubMed ID: 20659219)
1. Optimal management of hepatocellular carcinoma: challenges and opportunities.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2010 Aug; 25(8):1336-8. PubMed ID: 20659219
[No Abstract] [Full Text] [Related]
2. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
Hussain K; El-Serag HB
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
[TBL] [Abstract][Full Text] [Related]
4. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
5. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatocellular carcinoma in the age of liver transplantation.
Martin AP
Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
[TBL] [Abstract][Full Text] [Related]
7. Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
Mahady SE; Charlton B; Fitzgerald P; Koorey DJ; Perry JF; Waugh RC; McCaughan GW; Strasser SI
J Gastroenterol Hepatol; 2010 Jul; 25(7):1299-305. PubMed ID: 20594260
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: current management.
Cha CH; Saif MW; Yamane BH; Weber SM
Curr Probl Surg; 2010 Jan; 47(1):10-67. PubMed ID: 19963083
[No Abstract] [Full Text] [Related]
9. [Percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma].
Ebara M; Fukuda H; Yoshikawa M; Sugiura N; Saisho H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():545-51. PubMed ID: 11762009
[No Abstract] [Full Text] [Related]
10. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous ablation therapy for hepatocellular carcinomas.
D'Agostino HB; Solinas A
AJR Am J Roentgenol; 1995 May; 164(5):1165-7. PubMed ID: 7717225
[No Abstract] [Full Text] [Related]
12. General management.
Nguyen MH; Keeffe EB
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):161-74. PubMed ID: 15757811
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment for hepatocellular carcinoma.
Imaoka S; Sasaki Y
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():134-43. PubMed ID: 9210896
[No Abstract] [Full Text] [Related]
14. [Non-Surgical tumor ablation of hepatocellular carcinoma].
Koike Y; Omata M
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1276-9. PubMed ID: 14518406
[TBL] [Abstract][Full Text] [Related]
15. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.
Poon D; Anderson BO; Chen LT; Tanaka K; Lau WY; Van Cutsem E; Singh H; Chow WC; Ooi LL; Chow P; Khin MW; Koo WH;
Lancet Oncol; 2009 Nov; 10(11):1111-8. PubMed ID: 19880065
[TBL] [Abstract][Full Text] [Related]
16. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
Lencioni R; Crocetti L
Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
[TBL] [Abstract][Full Text] [Related]
17. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
Ichida T; Van Thiel DH; Hassanein T
Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
[TBL] [Abstract][Full Text] [Related]
18. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M
Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
[No Abstract] [Full Text] [Related]
19. Management of hepatocellular carcinoma.
Del Pozo AC; López P
Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
[TBL] [Abstract][Full Text] [Related]
20. Which matters most: number of tumors, size of the largest tumor, or total tumor volume?
Germani G; Gurusamy K; Garcovich M; Toso C; Fede G; Hemming A; Suh KS; Weber A; Burroughs AK
Liver Transpl; 2011 Oct; 17 Suppl 2():S58-66. PubMed ID: 21584928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
